GB9122609D0 - Improvements relating to the treatment of haemophilia - Google Patents

Improvements relating to the treatment of haemophilia

Info

Publication number
GB9122609D0
GB9122609D0 GB919122609A GB9122609A GB9122609D0 GB 9122609 D0 GB9122609 D0 GB 9122609D0 GB 919122609 A GB919122609 A GB 919122609A GB 9122609 A GB9122609 A GB 9122609A GB 9122609 D0 GB9122609 D0 GB 9122609D0
Authority
GB
United Kingdom
Prior art keywords
haemophilia
treatment
improvements relating
relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919122609A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GERRARD ANN J
Original Assignee
GERRARD ANN J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GERRARD ANN J filed Critical GERRARD ANN J
Priority to GB919122609A priority Critical patent/GB9122609D0/en
Publication of GB9122609D0 publication Critical patent/GB9122609D0/en
Priority to PCT/GB1992/001926 priority patent/WO1993007890A1/en
Priority to GB9222012A priority patent/GB2260702B/en
Priority to JP5507561A priority patent/JPH07502989A/ja
Priority to EP92921475A priority patent/EP0609293A1/en
Priority to AU27720/92A priority patent/AU2772092A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
GB919122609A 1991-10-24 1991-10-24 Improvements relating to the treatment of haemophilia Pending GB9122609D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB919122609A GB9122609D0 (en) 1991-10-24 1991-10-24 Improvements relating to the treatment of haemophilia
PCT/GB1992/001926 WO1993007890A1 (en) 1991-10-24 1992-10-20 Treatment of haemophilia
GB9222012A GB2260702B (en) 1991-10-24 1992-10-20 Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X
JP5507561A JPH07502989A (ja) 1991-10-24 1992-10-20 血友病の治療
EP92921475A EP0609293A1 (en) 1991-10-24 1992-10-20 Treatment of haemophilia
AU27720/92A AU2772092A (en) 1991-10-24 1992-10-20 Treatment of haemophilia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919122609A GB9122609D0 (en) 1991-10-24 1991-10-24 Improvements relating to the treatment of haemophilia

Publications (1)

Publication Number Publication Date
GB9122609D0 true GB9122609D0 (en) 1991-12-04

Family

ID=10703480

Family Applications (2)

Application Number Title Priority Date Filing Date
GB919122609A Pending GB9122609D0 (en) 1991-10-24 1991-10-24 Improvements relating to the treatment of haemophilia
GB9222012A Expired - Fee Related GB2260702B (en) 1991-10-24 1992-10-20 Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9222012A Expired - Fee Related GB2260702B (en) 1991-10-24 1992-10-20 Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X

Country Status (5)

Country Link
EP (1) EP0609293A1 (ja)
JP (1) JPH07502989A (ja)
AU (1) AU2772092A (ja)
GB (2) GB9122609D0 (ja)
WO (1) WO1993007890A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504074C2 (sv) † 1993-07-05 1996-11-04 Pharmacia Ab Proteinberedning för subkutan, intramuskulär eller intradermal administrering
IL113010A (en) * 1994-03-31 1999-10-28 Pharmacia & Upjohn Ab Pharmaceutical formulation comprising factor viii with an activity of at least 500iu/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
US7786070B2 (en) 1997-09-10 2010-08-31 Novo Nordisk Healthcare A/G Subcutaneous administration of coagulation factor VII
ES2449224T3 (es) 2000-05-03 2014-03-18 Novo Nordisk Health Care Ag Administración subcutánea del Factor de coagulación VII
KR20120061898A (ko) * 2009-08-20 2012-06-13 체에스엘 베링 게엠베하 출혈성 장애의 치료요법 및 예방 치료에 있어서의 비정맥내 투여를 위한 알부민 융합 응고 인자

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430930B1 (en) * 1985-03-15 1993-09-01 Btg International Limited Factor ix protein
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix

Also Published As

Publication number Publication date
WO1993007890A1 (en) 1993-04-29
JPH07502989A (ja) 1995-03-30
GB2260702B (en) 1995-09-20
GB2260702A (en) 1993-04-28
AU2772092A (en) 1993-05-21
GB9222012D0 (en) 1992-12-02
EP0609293A1 (en) 1994-08-10

Similar Documents

Publication Publication Date Title
GB9208339D0 (en) Treatment composition
GB9215633D0 (en) Novel treatment
GB9127150D0 (en) Novel treatment
GB9226860D0 (en) Novel treatment
GB9211148D0 (en) Novel treatment
GB9225860D0 (en) Novel treatment
GB2271579B (en) Treatment of wood
GB9201920D0 (en) Novel treatment i
GB9222012D0 (en) Improvements relating to the treatment of haemophilia
GB9111089D0 (en) Improvements in or relating to the treatment of waste
ZA933376B (en) Novel treatment
GB9203637D0 (en) Novel treatment
GB9225859D0 (en) Novel treatment
GB9022298D0 (en) Treatment composition
GB9125670D0 (en) Treatment of neurogical conditions
GB9105560D0 (en) Novel treatment i
RU1833739C (ru) Cпocoб лeчehия гипepkaлиemии
GB9212535D0 (en) Treatment of boimass
GB9225956D0 (en) Novel treatment
GB9225964D0 (en) Novel treatment
GB9225881D0 (en) Novel treatment
GB9225957D0 (en) Novel treatment
GB9225959D0 (en) Novel treatment
GB9225961D0 (en) Novel treatment
GB9225963D0 (en) Novel treatment

Legal Events

Date Code Title Description
730A Proceeding under section 30 patents act 1977